Treatment of prostatic cancer
Lehtonen, T.; Mäntylä, M.
Duodecim; Laaketieteellinen Aikakauskirja 95(12): 760-767
1979
ISSN/ISBN: 0012-7183 PMID: 520197 Document Number: 153617
Document emailed within 1 workday
Related Documents
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Rutkowski, A. 1980: Problems of treatment of prostatic cancer Wiadomosci Lekarskie 33(18): 1461-1466
Ogreid, P. 1986: Prostatic cancer. Treatment with LH-RH analogs Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(34-36): 2968-2970
Khazanov, V.G. 1989: The diagnosis and treatment of prostatic cancer Fel'dsher i Akusherka 54(6): 24-26
Fosså, S.D.; Miller, A. 1975: Treatment of advanced prostatic cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(13): 811-814
Ballanger, R.; Ballanger, P. 1980: Treatment of prostatic cancer with radiotherapy Acta Urologica Belgica 48(1): 86-91
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Murphy, G.P. 1987: To what degree is chemotherapy useful in the treatment of prostatic cancer Progress in Clinical and Biological Research 243b: 247-253
Murray, R.; Pitt, P. 1987: Aminoglutethimide in the treatment of advanced prostatic cancer Progress in Clinical and Biological Research 243a: 275-282
Auclerc, G. 2000: General treatment of metastatic prostatic cancer Annales d'Urologie 34(1): 39-48
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Beisland, H.O. 1988: Combined TUR and laser in the treatment of localized prostatic cancer Scandinavian Journal of Urology and Nephrology. Supplementum 110: 83-88
Olbrisch, R.R.; Sintermann, W.; Mauermayer, W. 1978: Andromastectomy for the prevention of gynecomastia in the treatment of prostatic cancer Fortschritte der Medizin 96(8): 372-373
Svensson, M.; Varenhorst, E.; Hjertberg, H.; Kågedal, B.; Nordenskjöld, B. 1987: Treatment of prostatic cancer with monthly injections of an LH-RH analog Lakartidningen 84(41): 3270-3271
Wemeau, L.; Mazeman, E.; Blanckaert, J.; Delhay, J. 1972: Results of hormone treatment of prostatic cancer. 168 cases Acta Urologica Belgica 40(1): 101-105